Based on the Solasia Pharma KK stock forecast from 0 analysts, the average analyst target price for Solasia Pharma KK is not available over the next 12 months. Solasia Pharma KK’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Solasia Pharma KK is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, Solasia Pharma KK’s stock price was JPY 41.00. Solasia Pharma KK’s stock price has changed by -8.89% over the past week, -6.82% over the past month and -25.45% over the last year.
No recent analyst target price found for Solasia Pharma KK
No recent average analyst rating found for Solasia Pharma KK
Company Overview Solasia Pharma KK
Solasia Pharma K.K. engages in the development and marketing of oncology drugs in Japan and other Asian countries. The company offers episil oral liquid for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy for cancer; Sancuso, a transdermal delivery system that delivers granisetron, an anti-emetic into the patient's bloodstream for the treatment of chemotherapy induced nausea and vomiting; and Darvias injection, and antineoplastic agent/organic arsenic product indicated for relapsed or refractory peripheral T-cell lymphoma. It is also involved in the development of SP-04, a chemotherapy induced peripheral neuropathy which is in pre-clinical stage. The company was founded in 2006 and is based in Tokyo, Japan. Read Less
Solasia Pharma K.K. engages in the development and marketing of oncology drugs in Japan and other Asian countries. The company offers episil oral liquid for the protection and relief of oral pain associated with oral mucositis/stomatitis caused by chemotherapy and radiotherapy fo...Read More
Frequently Asked Questions About Solasia Pharma KK (4597:TSE) Stock
Stock Target Advisor's fundamental analysis for Solasia Pharma KK's stock is Bearish.
Unfortunately we do not have enough data on 4597:TSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4597:TSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4597:TSE's stock to indicate if its overvalued.
The last closing price of 4597:TSE's stock was JPY 41.00.
The most recent market capitalization for 4597:TSE is JPY 9.79B.
Unfortunately we do not have enough analyst data on 4597:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Solasia Pharma KK's stock.
As per our most recent records Solasia Pharma KK has 24 Employees.
Solasia Pharma KK's registered address is Sumitomo Fudosan Shiba-Koen Tower, Tokyo, Japan, 105-0011.
You can get more information about it from Solasia Pharma KK's website at https://www.solasia.co.jp.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior Revenue Growth
This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Frequently Asked Questions About Solasia Pharma KK (4597:TSE) Stock
Stock Target Advisor's fundamental analysis for Solasia Pharma KK's stock is Bearish.
Unfortunately we do not have enough data on 4597:TSE's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on 4597:TSE's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on 4597:TSE's stock to indicate if its overvalued.
The last closing price of 4597:TSE's stock was JPY 41.00.
The most recent market capitalization for 4597:TSE is JPY 9.79B.
Unfortunately we do not have enough analyst data on 4597:TSE's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Solasia Pharma KK's stock.
As per our most recent records Solasia Pharma KK has 24 Employees.
Solasia Pharma KK's registered address is Sumitomo Fudosan Shiba-Koen Tower, Tokyo, Japan, 105-0011.
You can get more information about it from Solasia Pharma KK's website at https://www.solasia.co.jp.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for 4597:TSE !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
